NCM · Biotechnology

INDP (INDP) Stock

$1.39 -3.82% NCM: INDP Healthcare

Valuation

MetricValue
Price$1.39
Market Cap$2.43M
P/E Ratio-0.06
P/B Ratio0.72
P/S Ratio0.00
EPS (TTM)$-21.58
52-Week High$19.91
52-Week Low$0.92
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-700.00%
ROA-233.33%
ROCE-666.67%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-8.0M$-15.0M$-16.0M$-15.0M$-20.0M
Net Profit$-8.0M$-14.0M$-15.0M$-15.0M$-21.0M
EPS$-1.89$-1.73$-1.84$-1.61$-21.58
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$41.0M$28.0M$15.0M$7.0M$9.0M
Total Liabilities$5.0M$3.0M$3.0M$3.0M$6.0M
Cash$39.0M$10.0M$13.0M$6.0M$9.0M
Borrowings$0$0$0$0$0

Latest News

Top Premarket Decliners MT Newswires · Jun 5, 2026 Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-13.0M$-13.0M$-12.0M$-15.0M
Investing Cash Flow$0$-17.0M$17.0M$0$0
Financing Cash Flow$43.0M$0$0$-1.0M$0
Net Cash Flow$37.0M$-30.0M$4.0M$-8.0M$3.0M
Free Cash Flow$-11.0M$-13.0M$-13.0M$-12.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-802.01%
Quick Ratio2.34
Interest Coverage—
Return 1Y-76.87%
Return 3Y-94.70%
Return 5Y-99.25%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATXIAvenue Therapeutics, Inc. $0.26 -32.94% -0.49 $856691 0.00%
AZTR $0.14 +0.80% -0.09 $1.49M 0.00%
GTBP $0.29 -4.65% -0.07 $3.12M 0.00%
LIPOLipella Pharmaceuticals Inc. $0.07 +0.00% -0.05 $300354 0.00%
NKGNNKGen Biotech, Inc. $0.06 +0.00% -0.04 $7.84M 0.00%

About INDP

INDP is led by CEO Junyi Dai, employs 7 people, headquartered in US, publicly traded since 2015.

INDP stock trades at $1.39 with a market capitalization of $2.43M. The stock is valued at a price-to-earnings (P/E) ratio of -0.06, price-to-book of 0.72, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.92 and $19.91, and currently trades 93.0% below its 52-week high.

On profitability, INDP generates a return on equity (ROE) of -700.00%, return on capital employed of -666.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides